Leaders in Research Peptides

(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD
(£) GBP (Default)
  • ($) USD
  • (€) EUR
  • ($) AUD
  • ($) CAD
  • ($) NZD

ACE-031 Nasal Spray

£96.59£187.94

Buy ACE-031 Nasal Spray

ACE-031 is a healthy protein designed to initate a natural receptor in regulating muscle tissue’s development, strength, and function.

ACE-031 15ml contains: 1mg
ACE-031 30ml contains: 2mg

Buy 10 and get 10% Discount

476 in stock

Description

ACE-031 Nasal Peptide Spray New Zealand

This product is intended for research purposes only. To be used by trained professionals only.

ACE-031 Peptide is a novel therapeutic protein that has sparked significant interest in the field of medical research due to its potential applications in muscle-related disorders. This peptide belongs to the protein family and operates as a soluble form of the activin receptor type IIB (ActRIIB). ActRIIB is renowned for its essential role in regulating muscle growth, a function that ACE-031 Peptide leverages in its mechanism of action.

The way ACE-031 works is fascinating. It binds to myostatin and other similar ligands that inhibit muscle and protein growth, effectively blocking these inhibitory effects. Myostatin, specifically, is a protein produced by skeletal muscle cells that acts to limit muscle growth. By neutralizing the effects of myostatin, ACE-031 fosters an environment conducive to muscle development and preservation [1].

In New Zealand clinical trials, ACE-031 treatment was generally well-tolerated and led to increases in muscle mass in healthy postmenopausal women. Moreover, it has been studied extensively for its potential therapeutic benefits in treating Duchenne muscular dystrophy (DMD), a severe type of muscular disorder [2]. Preliminary findings suggest that this peptide may increase bone density and preserve muscle function in DMD patients, offering a promising avenue for future DMD therapies.

While ACE-031 is primarily used in laboratory research currently, its potential applications extend beyond this scope. Some New Zealand studies have indicated that ACE-031 may also enhance bone metabolism and limit lipid accumulation, further expanding its potential therapeutic uses. However, more research is needed to fully understand the peptide’s capabilities and safety profile.

In summary, ACE-031 is a potent muscle regulator with promising therapeutic potential. Its ability to block the inhibition of muscle growth and improve bone metabolism positions it as an exciting candidate for future research and development in the treatment of muscle-related pathologies [3].


References:

[1] https://pubmed.ncbi.nlm.nih.gov/ 23169607/

[2] https://pubmed.ncbi.nlm.nih.gov/ 27462804/

[3] https://www.clinicaltrialsarena.com/ projects/ace031forthetreatmen/


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our New Zealand Direct Peptides website: https://new-zealand.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.


BUY ACE-031 Nasal Spray ONLINE today From New Zealand Direct Peptides

You may also like…